Skip to content

Opus Genetics IRD Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$106.93M-82.4%-$49.59M+13.8%-$68.2M-151%-$58.28M-313%-$58.62M-419%
$53K+130%$53K+430%$50K+1,567%$37K+825%$23K+360%
$3.95M+20.1%$3.4M+1.1%$3.42M+4.3%$3.38M+9.9%$3.29M-10.9%
-$38.99M-35.1%-$35.25M-37.8%-$32.86M-$31.83M-$28.85M
$0-100%$302.5K-66.7%$605K0.0%$907.5K+200%
$0-100%$0-100%$1.21M$1.21M$1.21M
$57.15M+156%$50.02M+1,072%$25.91M+229%$21.72M+68.5%$22.36M+96.9%
-$5.37M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Opus Genetics generate?
Opus Genetics (IRD) generated -$39.0M in operating cash flow over the trailing twelve months.
Where does Opus Genetics's cash flow data come from?
Every line is extracted from Opus Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.